INTRODUCTION: Experiences of racial discrimination have been associated with poor health outcomes. Little is known, however, about how perceived racial discrimination influences DNA methylation (DNAm) among African Americans (AAs). We examined the association of experiences of discrimination with DNAm among AA women in the Intergenerational Impact of Genetic and Psychological Factors on Blood Pressure (InterGEN) study. METHODS: The InterGEN study examines the effects of genetic and psychological factors on blood pressure among AA women and their children. Measures include the Major Life Discrimination (MLD) and the Race-Related Events (RES) scales. In the present analysis, we examined discrimination and DNAm at baseline in the InterGEN study. The 850K EPIC Illumina BeadChip was used for evaluating DNAm in this epigenome-wide association study (EWAS). RESULTS: One hundred and fifty-two women contributed data for the RES-EWAS analysis and 147 for the MLD-EWAS analysis. Most were 30-39 years old, nonsmokers, had some college education, and had incomes <US$15,000/year. After controlling for age, smoking, and cell composition, MLD was significantly associated with DNAm at nine CpG (regions of DNA where a cytosine nucleotide is followed by a guanine nucleotide) sites (false discovery rate [FDR]-corrected p < .05). For the RES-EWAS analysis, no DNAm sites passed the epigenome-wide significance level after genomic control, though suggestive associations were observed at CpG sites after genomic control (raw p < 10-5). CONCLUSION: We observed significant epigenetic associations between disease-associated genes (e.g., schizophrenia, bipolar disorder, and asthma) and perceived discrimination as measured by the MLD Scale. Future health disparities research should include epigenetics in high-risk populations to elucidate functional consequences induced by the psychosocial environment.
INTRODUCTION: Experiences of racial discrimination have been associated with poor health outcomes. Little is known, however, about how perceived racial discrimination influences DNA methylation (DNAm) among African Americans (AAs). We examined the association of experiences of discrimination with DNAm among AA women in the Intergenerational Impact of Genetic and Psychological Factors on Blood Pressure (InterGEN) study. METHODS: The InterGEN study examines the effects of genetic and psychological factors on blood pressure among AA women and their children. Measures include the Major Life Discrimination (MLD) and the Race-Related Events (RES) scales. In the present analysis, we examined discrimination and DNAm at baseline in the InterGEN study. The 850K EPIC Illumina BeadChip was used for evaluating DNAm in this epigenome-wide association study (EWAS). RESULTS: One hundred and fifty-two women contributed data for the RES-EWAS analysis and 147 for the MLD-EWAS analysis. Most were 30-39 years old, nonsmokers, had some college education, and had incomes <US$15,000/year. After controlling for age, smoking, and cell composition, MLD was significantly associated with DNAm at nine CpG (regions of DNA where a cytosine nucleotide is followed by a guanine nucleotide) sites (false discovery rate [FDR]-corrected p < .05). For the RES-EWAS analysis, no DNAm sites passed the epigenome-wide significance level after genomic control, though suggestive associations were observed at CpG sites after genomic control (raw p < 10-5). CONCLUSION: We observed significant epigenetic associations between disease-associated genes (e.g., schizophrenia, bipolar disorder, and asthma) and perceived discrimination as measured by the MLD Scale. Future health disparities research should include epigenetics in high-risk populations to elucidate functional consequences induced by the psychosocial environment.
Entities:
Keywords:
African Americans; DNA methylation; epigenomics; racism; women
Authors: Longyue L Cao; Dario F Riascos-Bernal; Prameladevi Chinnasamy; Charlene M Dunaway; Rong Hou; Mario A Pujato; Brian P O'Rourke; Veronika Miskolci; Liang Guo; Louis Hodgson; Andras Fiser; Nicholas E S Sibinga Journal: Nature Date: 2016-11-09 Impact factor: 49.962
Authors: Elizabeth Brondolo; Leslie R M Hausmann; Juhee Jhalani; Melissa Pencille; Jennifer Atencio-Bacayon; Asha Kumar; Jasmin Kwok; Jahanara Ullah; Alan Roth; Daniel Chen; Robert Crupi; Joseph Schwartz Journal: Ann Behav Med Date: 2011-08
Authors: Cindy A Crusto; Veronica Barcelona de Mendoza; Christian M Connell; Yan V Sun; Jacquelyn Y Taylor Journal: Nurs Res Date: 2016 Jul-Aug Impact factor: 2.381
Authors: Elizabeth A Jacobs; Paul J Rathouz; Kelly Karavolos; Susan A Everson-Rose; Imke Janssen; Howard M Kravitz; Tené T Lewis; Lynda H Powell Journal: J Womens Health (Larchmt) Date: 2013-11-21 Impact factor: 2.681
Authors: Lorelei D Shoemaker; Michael J Clark; Anil Patwardhan; Gemma Chandratillake; Sarah Garcia; Rong Chen; Alexander A Morgan; Nan Leng; Scott Kirk; Richard Chen; Douglas J Cook; Michael Snyder; Gary K Steinberg Journal: G3 (Bethesda) Date: 2015-11-03 Impact factor: 3.542
Authors: Jacquelyn Y Taylor; Yan V Sun; Veronica Barcelona de Mendoza; Mosi Ifatunji; Jane Rafferty; Ervin R Fox; Solomon K Musani; Mario Sims; James S Jackson Journal: Medicine (Baltimore) Date: 2017-10 Impact factor: 1.889
Authors: Janelle E Letzen; Vani A Mathur; Mary R Janevic; Michael D Burton; Anna M Hood; Calia A Morais; Staja Q Booker; Claudia M Campbell; Edwin N Aroke; Burel R Goodin; Lisa C Campbell; Ericka N Merriwether Journal: J Pain Date: 2022-02-26 Impact factor: 5.383
Authors: Hudson P Santos; Benjamin C Nephew; Arjun Bhattacharya; Xianming Tan; Laura Smith; Reema Abdulrahman S Alyamani; Elizabeth M Martin; Krista Perreira; Rebecca C Fry; Christopher Murgatroyd Journal: Psychoneuroendocrinology Date: 2018-08-16 Impact factor: 4.905
Authors: Janet K Williams; Vence L Bonham; Catherine Wicklund; Bernice Coleman; Jacquelyn Y Taylor; Ann K Cashion Journal: Nurs Outlook Date: 2019-06-18 Impact factor: 3.315